Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 7/7/2020
SIETES contiene 93061 citas

 
 
 1 a 20 de 561 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P, Fernández J, Prati D, Baselli G, Asselta R, Grimsrud MM, Milani C, et al. for The Severe Covid-19 GWAS. Genomewide association study of severe covid-19 with respiratory failure. N Engl J Med 2020:17 de junio. [Ref.ID 103670]
2.Enlace a cita original Cita con resumen
Tangamornsuksan W, Lohitnavy M. Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. JAMA Dermatol 2018;154:1 de abril. [Ref.ID 102558]
3. Cita con resumen
Nordström P, Pedersen NL, Gustafson Y, Michäelsson k, Nordström A. Risks of myocardial infarction, death, and diabetes in identical twin pairs with different body mass indexes. JAMA Intern Med 2016:1 de agosto. [Ref.ID 100560]
4. Cita con resumen
Wang Y, Zhao X, Lin J, Johnston C, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, for the CHANCE Investigators. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 2016;316:70-8. [Ref.ID 100516]
5.Tiene citas relacionadas Cita con resumen
Ko TM, Tsai CY, Chen S-Y, Chen KS, Yu K-H, Chu C-S, Huang CM, Wang CR, Weng C-T, Yu C-L, Hsieh S-C, Tsai J-C, Lai W-T, Tsai W-C, Yin G-D, Ou T-T, Cheng K-H, Yen J-H, Liou T-L, Lin T-H, Chen D-Y, Hsiao P-J, Chen DY, Weng M-Y, Chen Y-M, Chen C-H, Liu F-M, Yen H-W, Lee J-J, Hung S-Y, Luo S-F, Yang Y-H, Chuang H-P, Chou Y-C, Liao H-T, Wang C-W, Huang C-L, Chen P, Wong C-S, Wu J-Y, Chen Y-T, Shen C-Y, for the Taiwan Allopurinol-SCAR Consortium. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ 2015;351:h4848. [Ref.ID 99587]
6.Tiene citas relacionadas Cita con resumen
Li-Wan-Po A. Pharmacogenetics begins to deliver on its promises. BMJ 2015;351:h5042. [Ref.ID 99584]
7. Cita con resumen
McElduff A. Non-type 1, non-type 2 diabetes: what's in a name?. Australian Prescriber 2013;36:196-8. [Ref.ID 95647]
8. Cita con resumen
Anónimo. Supreme Court rules human genes cannot be patented. DIA Daily 2013:14 de junio. [Ref.ID 95627]
9. Cita con resumen
Bergendal A, Adami J, Bahmanyar S, Hedenmalm K, Lärfars G, Persson I, Sundström A, Kieler H. Non-steroidal anti-inflammatory drugs and venous thromboembolism in women. Pharmacoepidemiol Drug Saf 2013;22:658-66. [Ref.ID 95564]
10.Tiene citas relacionadas
Andersson C, Gislason GH, Torp-Pedersen C. Treatment with clopidogrel after myocardial infarction - Reply. JAMA 2012;308:2457. [Ref.ID 94264]
11.Tiene citas relacionadas
Lin G-M, Li Y-H, Han C-L. Treatment with clopidogrel after myocardial infarction. JAMA 2012;308:2456-7. [Ref.ID 94263]
12.Tiene citas relacionadas
Den Ruijter HM, Bots ML. Treatment with clopidogrel after myocardial infarction. JAMA 2012;308:2456. [Ref.ID 94262]
13.Tiene citas relacionadas
14.Tiene citas relacionadas Cita con resumen
Andersson C, Lyngbaek S, Nguyen CD, Gislason GH, Kober L, Torp-Pedersen C. Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and whithout diabetes. JAMA 2012;308:882-9. [Ref.ID 93727]
15. Cita con resumen
Clarke R, Bennett DA, Parish S, Verhoef P, Dötsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, Saleheen D, Tanaka T, Anand SS, Chambers JC, Kleber ME, Ouwehand WH, Yamada Y, Elbers C, Peters B, Stweart AFR, Reilly MM, Thorand B, Yusuf S, Engert JC, Assimes TL, Kooner J, Danesh J, Watkins H, Samani NJ, Collins R, Peto R, for the MTHFR Studies Collaborative Group. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLOS Medicine 2012:febrero. [Ref.ID 92301]
16. Cita con resumen
Domchek SM, Friebel TM, Singer CF, Evans DGL, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R, Pichert G, Van t'veer L, Tung N, Weitzel JN, Couch FJ, Rubinstein WS, Ganz PA, Daly MB, Olopade OI, Tomlinson G, Schildkraut J, Blum JL, Rebbeck TR. Association or risc-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967-75. [Ref.ID 89281]
18.Tiene citas relacionadas
Michaëlsson K. Cardiovascular disease, hypertension, and risk of hip fracture. In reply. JAMA 2010;303:731-2. [Ref.ID 87925]
19.Tiene citas relacionadas
Strandberg TE. Cardiovascular disease, hypertension, and risk of hip fracture. JAMA 2010;303:731. [Ref.ID 87924]
20. Cita con resumen
Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaëlsson K. Cardiovascular diseases and risk of hip fracture. JAMA 2009;302:1666-73. [Ref.ID 86980]
Seleccionar todas
 
 1 a 20 de 561 siguiente >>